Eptifibatide Ctruz
Eptifibatide Ctruz is a medicine that helps prevent blood clots by stopping platelets from clumping together.
Form
infuusioneste, liuos
Strength
0.75 mg/ml
Active Ingredient
Eptifibatide
Manufacturer
Ctruz ApS
How to Use
Dosage
The recommended dose is 180 micrograms per kilogram (mcg/kg) given as a quick injection into a vein. After that, you will receive a continuous infusion of 2 mcg/kg per minute. If you have kidney problems, the infusion dose might be lowered to 1 mcg/kg per minute.
Method
This medicine is given as a single quick injection directly into a vein, followed by a continuous drip (infusion).
Important
The infusion can be given for up to 72 hours. If you have a special heart procedure (PCI), the infusion may continue for up to 96 hours.
Possible Side Effects
COMMON
- •Minor or major bleeding (e.g., blood in urine, stools, vomit, or during surgery)
- •Anemia (low red blood cell count)
- •Inflammation of a vein (phlebitis)
RARE
- •Reduced number of platelets (blood cells needed for clotting)
- •Reduced blood flow to the brain
- •Severe bleeding (e.g., internal bleeding in the stomach, brain, or lungs)
- •Bleeding leading to death
- •Skin rash (like hives)
- •Sudden, severe allergic reaction
Important Warnings
- Do not use if you are allergic to Eptifibatide Ctruz or any of its ingredients.
- Do not use if you have had recent bleeding (stomach, intestines, bladder, or other organs) or a stroke in the last 30 days.
- Do not use if you have a brain tumor or a condition affecting blood vessels in your brain.
- Do not use if you have had major surgery or a severe injury in the last 6 weeks.
- Do not use if you have bleeding problems, trouble with blood clotting, or a low number of platelets.
Show 7 more warnings
- Do not use if you have very high blood pressure or severe kidney or liver problems.
- Do not use if you are already taking another medicine similar to Eptifibatide Ctruz.
- This medicine should only be used by adults in a hospital heart monitoring unit.
- You will have blood tests before and during treatment to check for bleeding.
- You will be carefully watched for any unusual bleeding during treatment.
- Do not give to children or teenagers under 18 years old.
- If you are breastfeeding, you must stop during treatment.